NCT04526509 2024-11-26Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid TumorsAdaptimmunePhase 1 Terminated12 enrolled 12 charts
NCT05943990 2024-11-13Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell LiposarcomaAdaptimmunePhase 1 Terminated5 enrolled 16 charts
NCT06048705 2024-11-13Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung CancerAdaptimmunePhase 1 Terminated7 enrolled 19 charts